脑脊液D-二聚体评估胶质瘤脑室侵犯和脊髓播散的临床意义

陈建新; 康　勋; 李　岩

doi:10.19401/j.cnki.1007-3639.2018.09.001

您当前的位置：

首页 >

文章列表页 >

脑脊液D-二聚体评估胶质瘤脑室侵犯和脊髓播散的临床意义

专家述评与论著 | 更新时间：2026-01-27

- 脑脊液D-二聚体评估胶质瘤脑室侵犯和脊髓播散的临床意义
- Clinical significance of cerebrospinal fluid D-dimer in glioma patients with ventricular metastasis and spinal cord metastasis
- 中国癌症杂志 2018年28卷第9期页码：641-648
- 作者机构：
  
  1. 首都医科大学附属北京世纪坛医院脑胶质瘤科,北京,100038
  2. 首都医科大学附属北京天坛医院神经肿瘤综合治疗科,北京,100050
- 作者简介：
- 基金信息：
- DOI：10.19401/j.cnki.1007-3639.2018.09.001
  中图分类号： R739.41
- 网络出版：2018-10-26，
  
  纸质出版：2018-10-26
- 稿件说明：
移动端阅览
陈建新,康　勋,李　岩,等. 脑脊液D-二聚体评估胶质瘤脑室侵犯和脊髓播散的临床意义[J]. 中国癌症杂志, 2018, 28(9): 641-648.

陈建新, 康　勋, 李　岩. Clinical significance of cerebrospinal fluid D-dimer in glioma patients with ventricular metastasis and spinal cord metastasis[J]. China Oncology, 2018, 28(9): 641-648.
陈建新,康　勋,李　岩,等. 脑脊液D-二聚体评估胶质瘤脑室侵犯和脊髓播散的临床意义[J]. 中国癌症杂志, 2018, 28(9): 641-648. DOI： 10.19401/j.cnki.1007-3639.2018.09.001.

陈建新, 康　勋, 李　岩. Clinical significance of cerebrospinal fluid D-dimer in glioma patients with ventricular metastasis and spinal cord metastasis[J]. China Oncology, 2018, 28(9): 641-648. DOI： 10.19401/j.cnki.1007-3639.2018.09.001.

摘要

背景与目的：胶质瘤是最常见的原发中枢神经系统肿瘤，该研究通过测定胶质瘤患者脑脊液和血浆D-二聚体水平，探讨脑脊液和血浆D-二聚体评估胶质瘤脑室侵犯（ventricular metasasis，VM）和脊髓播散（spinal cord metastasis，SCM）的临床意义。方法：83例胶质瘤患者根据不同临床特点分为未复发组和复发组；脑实质组、VM组和SCM组；原发脊髓播散（primary spinal cord metastasis，PSCM）组和继发脊髓播散（secondary spinal cord metastasis，SSCM）组，化疗前检测患者脑脊液和血浆D-二聚体，分析脑脊液和血浆D-二聚体水平与胶质瘤VM和SCM的关系。结果：复发组脑脊液D-二聚体显著高于未复发组（P=0.000 3），SCM组显著高于VM组（P=0.001 5），VM组和SCM组显著高于脑实质组（P=0.000 1，P=0.000 3），SSCM组显著高于PSCM组（P=0.000 5），VM组（P=0.000 1）和SCM组（P=0.005 0）治疗后减少差异有统计学意义。SCM组血浆D-二聚体显著高于VM组（P=0.023 5）和脑实质组（P=0.000 5），复发组与未复发组（P=0.371 8）、PSCM组与SSCM组（P=0.059 2）差异无统计学意义，VM组（P=0.182 4）和SCM组（P=0.093 3）治疗后减少差异也无统计学意义。受试者工作特征（receiver operating characteristic，ROC）曲线中脑脊液和血浆D-二聚体的截断值分别为69和219 ng/mL，灵敏度和特异度分别为86.75%、94.12%和34.94%、94.12%。结论：脑脊液D-二聚体可作为特异性预示胶质瘤VM或SCM和评估疗效的良好标志物。

Abstract

Background and purpose: Glioma is the most common primary tumor of the central nervous system. This study aimed to investigate the clinical significance of cerebrospinal fluid (CSF) and plasma D-dimer levels and the relation with ventricular metastasis (VM) and spinal cord metastasis (SCM) of glioma. Methods: The CSF and plasma D-dimer levels were measured in 83 glioma patients. The glioma patients were divided into unrelapsed group and relapse group; parenchyma group

VM group and SCM group; primary spinal cord metastasis (PSCM) group and secondary spinal cord metastasis (SSCM) group according to the clinical characteristics. We investigated the relationship between the levels of CSF or plasma D-dimer and spinal cord metastasis or ventricular metastasis of glioma. Results: The CSF D-dimer level of relapse group was significantly higher than that of unrelapsed group (P=0.000 3). The CSF D-dimer level of SCM group was significantly higher than that of VM group (P=0.001 5). The CSF D-dimer levels of VM and SCM groups were significantly higher compared with parenchyma group (P=0.000 1

P=0.000 3). The CSF D-dimer level of SSCM group was significantly higher than that of PSCM group (P=0.000 5). The CSF D-dimer levels of VM (P=0.0001) and SCM groups (P=0.005 0) were significantly reduced after chemotherapy. The plasma D-dimer level of SCM group was significantly higher compared with VM group (P=0.023 5) and parenchyma group (P=0.000 5). There was no significant difference in the plasma D-dimer level between unrelapsed and relapse groups (P=0.371 8) or PSCM and SSCM groups (P=0.059 2). The plasma D-dimer levels of VM group (P=0.182 4) and SCM group (P=0.093 3) did not decrease significantly after chemotherapy. In the receiver operating characteristic (ROC) curve

the optimal cut-off points for CSF and plasma D-dimer levels were found to be 69 and 219 ng/mL in glioma patients with sensitivity and specificity of 86.75 %

94.12% and 34.94%

94.12%

respectively. Conclusion: D-dimer might be an important clinical marker for spinal cord metastasis or ventricular metastasis and response evaluation in glioma.

关键词

Keywords

references

浏览量

1923

下载量

CSCD

文章被引用时，请邮件提醒。

提交

工具集

关联资源

胶质瘤中MGMT甲基化状态及其临床意义的回顾性研究

WTAP通过调节BMI1 mRNA的m6A修饰促进胶质瘤细胞增殖和有氧糖酵解

胶质母细胞瘤复发相关基因的筛选、表达和临床预后分析

CHKA基因沉默对胶质瘤细胞生物学行为的影响及其机制

微流控芯技术检测循环肿瘤细胞在脑胶质瘤预后预测中的价值